| Identification | Back Directory | [Name]
SPARC (119-122) (MOUSE) | [CAS]
155149-79-4 | [Synonyms]
Tetrapeptide-3
LYS-GLY-HIS-LYS
H-LYS-GLY-HIS-LYS-OH
SPARC (119-122) (MOUSE)
L-Lysylglycyl-L-histidyl-L-lysine
L-Lysine, L-lysylglycyl-L-histidyl-
SPARC (119-122) (mouse) acetate salt H-Lys-Gly-His-Lys-OH acetate salt
(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid | [EINECS(EC#)]
-0 | [Molecular Formula]
C20H36N8O5 | [MDL Number]
MFCD01310915 | [MOL File]
155149-79-4.mol | [Molecular Weight]
468.55 |
| Chemical Properties | Back Directory | [Boiling point ]
978.7±65.0 °C(Predicted) | [density ]
1.280±0.06 g/cm3(Predicted) | [storage temp. ]
-15°C
| [pka]
3.16±0.10(Predicted) | [Sequence]
Lys-Gly-His-Lys |
| Hazard Information | Back Directory | [Uses]
SPARC (119-122) (mouse) stimulates endothelial cell proliferation and angiogenesis. SPARC (119-122) (mouse) can be used to enhance neovascularization in modified polypropropylene biomaterials[1]. | [References]
[1] Navdeep B Malkar, et al. Characterization of peptide-amphiphiles possessing cellular activation sequences. Biomacromolecules. 2003 May-Jun;4(3):518-28. DOI:10.1021/bm0256597 |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|